Pilot & Feasibility
Protocols & Methods
Reagents & Resources
Tissues & Samples
IMPC / KOMP Data
Pilot & Feasibility
Targeting the Diabetic Chaperome to Improve Peripheral Neuropathy.
Rick Dobrowsky on 8/1/2016
Current diabetes reports
Volume : Pages
16 : 71
The chaperome constitutes a broad family of molecular chaperones and
co-chaperones that facilitate the folding, refolding, and degradation of the
proteome. Heat shock protein 90 (Hsp90) promotes the folding of numerous
oncoproteins to aid survival of malignant phenotypes, and small molecule
inhibitors of the Hsp90 chaperone complex offer a viable approach to treat
certain cancers. One therapeutic attribute of this approach is the selectivity
of these molecules to target high affinity oncogenic Hsp90 complexes present in
tumor cells, which are absent in nontransformed cells. This selectivity has
given rise to the idea that disease may contribute to forming a stress chaperome
that is functionally distinct in its ability to interact with small molecule
Hsp90 modulators. Consistent with this premise, modulating Hsp90 improves
clinically relevant endpoints of diabetic peripheral neuropathy but has little
impact in nondiabetic nerve. The concept of targeting the "diabetic chaperome"
to treat diabetes and its complications is discussed.
Neuropathy & Neurocognition
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an external advisor to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!